These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34845969)
1. Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling. Zhou Q; Yuan J; Liu Y; Wu Y Bioengineered; 2021 Dec; 12(2):11213-11224. PubMed ID: 34845969 [TBL] [Abstract][Full Text] [Related]
2. Cisatracurium-induced proliferation impairment and death of colorectal cancer cells, HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro. Yabasin IB; Lu Z; Yu JC; Wen Q Biomed Pharmacother; 2017 Jul; 91():320-329. PubMed ID: 28463795 [TBL] [Abstract][Full Text] [Related]
3. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice. Bryson HM; Faulds D Drugs; 1997 May; 53(5):848-66. PubMed ID: 9129870 [TBL] [Abstract][Full Text] [Related]
4. Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21. Zhu D; Shi C; Jiang Y; Zhu K; Wang X; Feng W Bioengineered; 2021 Dec; 12(1):1505-1516. PubMed ID: 33944652 [TBL] [Abstract][Full Text] [Related]
5. Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling. Yang ZC; Ma J Biochem Biophys Res Commun; 2018 Mar; 497(4):1177-1183. PubMed ID: 27914809 [TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil enhances the chemosensitivity of gastric cancer to TRAIL via inhibition of the MAPK pathway. Li H; Lv J; Guo J; Wang S; Liu S; Ma Y; Liang Z; Wang Y; Qi W; Qiu W Biochem Biophys Res Commun; 2021 Feb; 540():108-115. PubMed ID: 33476960 [TBL] [Abstract][Full Text] [Related]
7. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089 [TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation. Hong M; Li J; Li S; M Almutairi M Cells; 2019 Nov; 8(11):. PubMed ID: 31752383 [TBL] [Abstract][Full Text] [Related]
10. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway. Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers. Nazim UM; Rasheduzzaman M; Lee YJ; Seol DW; Park SY Oncotarget; 2017 Mar; 8(11):18095-18105. PubMed ID: 28178647 [TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Lee DH; Rhee JG; Lee YJ Br J Pharmacol; 2009 Aug; 157(7):1189-202. PubMed ID: 19438509 [TBL] [Abstract][Full Text] [Related]
13. The synergistic effects of low dose fluorouracil and TRAIL on TRAIL-resistant human gastric adenocarcinoma AGS cells. Zhu H; Huang M; Ren D; He J; Zhao F; Yi C; Huang Y Biomed Res Int; 2013; 2013():293874. PubMed ID: 24324958 [TBL] [Abstract][Full Text] [Related]
14. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663 [TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776 [TBL] [Abstract][Full Text] [Related]
16. GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells. Wu YY; Hsieh CT; Chiu YM; Chou SC; Kao JT; Shieh DC; Lee YJ PLoS One; 2018; 13(12):e0208094. PubMed ID: 30557366 [TBL] [Abstract][Full Text] [Related]
17. Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation. Park EJ; Choi KS; Yoo YH; Kwon TK Anticancer Drugs; 2013 Mar; 24(3):260-9. PubMed ID: 23187459 [TBL] [Abstract][Full Text] [Related]
18. Andrographolide Enhances TRAIL-Induced Apoptosis via Deng Y; Bi R; Guo H; Yang J; Du Y; Wang C; Wei W Int J Biol Sci; 2019; 15(3):688-700. PubMed ID: 30745855 [TBL] [Abstract][Full Text] [Related]
19. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway. Wang WQ; Zhang H; Wang HB; Sun YG; Peng ZH; Zhou G; Yang SM; Wang RQ; Fang DC Mol Diagn Ther; 2010 Jun; 14(3):155-61. PubMed ID: 20560677 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling. Rasheduzzaman M; Jeong JK; Park SY Life Sci; 2018 Sep; 208():208-220. PubMed ID: 30031063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]